Frontiers
US$ 27.74
foxo4 dri peptide senolytic mouse study 2023 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells Targeted Apoptosis of Senescent Cells
Description
Back to Products Product is designed as diluent for reconstitution of lyophilised peptides
The sustained effects of a dual GIP/GLP-1 receptor agonist, NNC00902746, in patients with type 2 diabetes
Android phone or tablet (4.1 or higher): Click here iPhone, iPad & iPad Pro (iOS 8 or higher): Click here Were Hiring
Vitamin B 12deficiency that is allowed to progress for longer than 3 months may produce permanent degenerative lesions of the spinal cord
